Target intelligence / Profile preview

Keratin and other stratum corneum proteins (SC proteins)

Target
SC proteins
Molecular classification
Structural protein, Intermediate filament, Cornified envelope protein
01

Overview

The stratum corneum is the outermost layer of the epidermis, acting as the body's primary physical and chemical barrier against environmental insults. It consists of corneocytes, which are dead, flattened cells filled with a dense network of keratin intermediate filaments (primarily KRT1 and KRT10) and encased in a highly cross-linked cornified envelope composed of proteins like filaggrin, loricrin, and involucrin (StatPearls, NBK513299). These proteins provide structural rigidity and are essential for maintaining skin hydration and preventing transepidermal water loss (PubMed, 23945662). In various dermatological conditions such as psoriasis and ichthyosis, abnormal keratinization leads to the accumulation of these proteins, resulting in thickened, scaly skin (NIH, Filaggrin). Therapeutic strategies targeting these proteins often utilize keratolytic agents like salicylic acid or urea, which chemically disrupt the protein structures or the 'intercellular cement' to promote the shedding of excess cornified tissue (PubChem, Salicylic acid). Additionally, retinoids are used to modulate the gene expression of these proteins to normalize the differentiation process of keratinocytes (Journal of Clinical and Aesthetic Dermatology, Keratolytics).

Other names
Stratum corneum proteinsCornified envelope proteinsEpidermal keratinsCorneocyte proteins
02

Mechanism of action

Keratolytic agents interact with these proteins by increasing hydration, which causes the cornified epithelium to swell and soften, or by disrupting the intercellular desmosomes and protein-lipid matrices that hold corneocytes together, thereby facilitating desquamation.

03

Biological functions

Skin barrier formationMechanical protectionWater retentionDesquamationInnate immune defense
04

Disease associations

PsoriasisIchthyosisAtopic dermatitisHyperkeratosisVerruca vulgarisActinic keratosis
05

Safety considerations

Skin irritation and erythemaIncreased photosensitivitySystemic toxicity (e.g., salicylism) upon extensive topical applicationImpaired barrier function leading to secondary infections
06

Interacting drugs

Salicylic acid

7 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL)Filaggrin (FLG) expression levelsKeratin 10 (KRT10) expressionCorneocyte surface area

Beyond the preview

Go deeper on Keratin and other stratum corneum proteins (SC proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin and other stratum corneum proteins (SC proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call